Germany · Delayed Price · Currency is EUR Rhythm Pharmaceuticals Statistics
Total Valuation
FRA:1RV has a market cap or net worth of EUR 6.03 billion. The enterprise value is 5.90 billion.
| Market Cap | 6.03B |
| Enterprise Value | 5.90B |
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.74M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.39% |
| Shares Change (QoQ) | +4.05% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 90.43% |
| Float | 55.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.58 |
| PB Ratio | 23.93 |
| P/TBV Ratio | 49.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -34.99 |
| EV / Sales | 39.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.38.
| Current Ratio | 4.75 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.70 |
Financial Efficiency
Return on equity (ROE) is -85.79% and return on invested capital (ROIC) is -34.50%.
| Return on Equity (ROE) | -85.79% |
| Return on Assets (ROA) | -26.74% |
| Return on Invested Capital (ROIC) | -34.50% |
| Return on Capital Employed (ROCE) | -46.25% |
| Revenue Per Employee | 525,035 |
| Profits Per Employee | -595,438 |
| Employee Count | 283 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.03 |
Taxes
In the past 12 months, FRA:1RV has paid 373,307 in taxes.
| Income Tax | 373,307 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +54.31% |
| 50-Day Moving Average | 87.68 |
| 200-Day Moving Average | 68.47 |
| Relative Strength Index (RSI) | 52.16 |
| Average Volume (20 Days) | 8 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.53 |
Income Statement
In the last 12 months, FRA:1RV had revenue of EUR 148.58 million and -168.51 million in losses. Loss per share was -2.65.
| Revenue | 148.58M |
| Gross Profit | 132.84M |
| Operating Income | -158.71M |
| Pretax Income | -163.55M |
| Net Income | -168.51M |
| EBITDA | -157.47M |
| EBIT | -158.71M |
| Loss Per Share | -2.65 |
Balance Sheet
The company has 354.60 million in cash and 96.40 million in debt, giving a net cash position of 258.20 million.
| Cash & Cash Equivalents | 354.60M |
| Total Debt | 96.40M |
| Net Cash | 258.20M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 252.01M |
| Book Value Per Share | 1.90 |
| Working Capital | 332.85M |
Cash Flow
| Operating Cash Flow | -93.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 89.40%, with operating and profit margins of -106.81% and -110.32%.
| Gross Margin | 89.40% |
| Operating Margin | -106.81% |
| Pretax Margin | -110.07% |
| Profit Margin | -110.32% |
| EBITDA Margin | -105.98% |
| EBIT Margin | -106.81% |
| FCF Margin | n/a |
Dividends & Yields
FRA:1RV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.39% |
| Shareholder Yield | -5.39% |
| Earnings Yield | -2.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:1RV has an Altman Z-Score of 8.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.47 |
| Piotroski F-Score | 5 |